These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23940451)

  • 21. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
    Mehta RH; Ou FS; Peterson ED; Shaw RE; Hillegass WB; Rumsfeld JS; Roe MT;
    JACC Cardiovasc Interv; 2009 Jan; 2(1):56-64. PubMed ID: 19463399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.
    Zeymer U; Huber K; Fu Y; Ross A; Granger C; Goldstein P; van de Werf F; Armstrong P;
    Eur Heart J Acute Cardiovasc Care; 2012 Jun; 1(2):136-42. PubMed ID: 24062901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.
    Hussain M; Kumar R; Ammar A; Alishan S; Muhammad AS; Farooq F; Saghir T; Khan N; Hassan Rizvi SN; Ashraf T
    Cureus; 2020 Dec; 12(12):e12036. PubMed ID: 33457136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
    Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
    Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of infarct-related artery patency following combined lytic therapy in patients with ST-segment elevation myocardial infarction treated with immediate percutaneous coronary intervention.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Bierca K; Legutko J; Dubiel JS; Dudek D
    Kardiol Pol; 2011; 69(5):452-7. PubMed ID: 21594830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Admission Neutrophil to Lymphocyte Ratio Predict Infarct-Related Artery Patency in ST-Segment Elevation Myocardial Infarction.
    Doğan M; Akyel A; Bilgin M; Erat M; Çimen T; Sunman H; Efe TH; Açıkel S; Yeter E
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):172-6. PubMed ID: 24322278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil to lymphocyte ratio in acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Turan B; Kiliçgedik A; Karabay CY; Akgün T; Güler A; Pala S; Kirma C
    Am J Med Sci; 2014 Jul; 348(1):37-42. PubMed ID: 24172233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Li J; Zhou Y; Zhang Y; Zheng J
    BMC Cardiovasc Disord; 2018 Jun; 18(1):125. PubMed ID: 29940881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Selected Baseline and Post-PCI Electrocardiographic Parameters as Predictors of Left Ventricular Systolic Dysfunction after a First ST-Segment Elevation Myocardial Infarction.
    Fabiszak T; Kasprzak M; Koziński M; Kubica J
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention.
    Verdoia M; Gioscia R; Viola O; Brancati MF; Soldà PL; Rognoni A; De Luca G;
    J Cardiovasc Med (Hagerstown); 2023 Sep; 24(9):631-636. PubMed ID: 37605955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Basar N; Sen N; Ozcan F; Erden G; Kanat S; Sokmen E; Isleyen A; Yuzgecer H; Ozlu MF; Yildirimkaya M; Maden O; Covic A; Johnson RJ; Kanbay M
    J Investig Med; 2011 Aug; 59(6):931-7. PubMed ID: 21415772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI - The Tamip Study.
    Balghith MA
    Heart Views; 2012 Jul; 13(3):85-90. PubMed ID: 23181175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction.
    Wagdy S; Sobhy M; Loutfi M
    Clin Med Insights Cardiol; 2016; 10():19-22. PubMed ID: 26884687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Serum Copeptin Levels with Patency of Infarct-Related Arteries in Patients with ST-Segment Elevation Myocardial Infarction.
    Doganay B; Okutucu S; Cetin M; Kızıltunc E; Karayigit O; Ozkan C; Kılınckaya MF; Ornek E
    Acta Cardiol Sin; 2019 Jul; 35(4):360-368. PubMed ID: 31371896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-procedural TIMI flow grade 2 is not associated with improved prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary revascularization (PL-ACS registry).
    Karwowski J; Poloński L; Gierlotka M; Gąsior M; Bęćkowski M; Kowalik I; Szwed H
    Cardiol J; 2016; 23(4):402-10. PubMed ID: 27296160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
    Giralt T; Ribas N; Freixa X; Sabaté M; Caldentey G; Tizón-Marcos H; Carrillo X; García-Picart J; Lidón RM; Cárdenas M; Pérez-Fernández S; Mauri J; Vaquerizo B
    Int J Cardiol; 2021 Feb; 325():9-15. PubMed ID: 32991944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship Between High Sensitivity C-reactive Protein to Albumin Ratio With Infarct-related Artery Patency in Patients With Non-ST-segment Elevation Myocardial Infarction.
    Özkan C; Karayiğit O
    Angiology; 2024 Aug; 75(7):682-688. PubMed ID: 37236654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Estévez-Loureiro R; Salgado-Fernández J; Marzoa-Rivas R; Barge-Caballero E; Pérez-Pérez A; Noriega-Concepción V; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A; Kaski JC
    Thromb Res; 2009 Nov; 124(5):536-40. PubMed ID: 19467699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between infarct artery location, acute total coronary occlusion, and mortality in STEMI and NSTEMI patients.
    Karwowski J; Gierlotka M; Gąsior M; Poloński L; Ciszewski J; Bęćkowski M; Kowalik I; Szwed H
    Pol Arch Intern Med; 2017 Jun; 127(6):401-411. PubMed ID: 28475171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.